glp 1 and gip medication Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: SURMOUNT-1 (tirzepatide/Zepbound, 72 weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). For educational comparison only—these are GLP-1 Agonists for Addiction

It also preserves myocardial structure by preventing desmin degradation and attenuating fibrosis via inhibition of the iNOS/mTOR/TIMP-1 pathway, thereby reducing collagen deposition and normalizing cardiac electrical activity (Yang et al., 2020

Pancreatic and Thyroid Risks: While rare, there are concerns about potential risks such as acute pancreatitis, gallbladder disease, and an increased risk of thyroid C-cell tumors (based on animal studies)

If you discontinue the medication, taste disturbances typically resolve within days to weeks, depending on the drug's half-life (for example, semaglutide has a half-life of approximately one week, so effects may persist for several weeks after stopping)

At the time this overview was prepared, the website displayed one-, three-, and six-bottle options with different per-bottle pricing and shipping terms